|
Originally published In Press as doi:10.1074/jbc.M413929200 on May 10, 2005
J. Biol. Chem., Vol. 280, Issue 26, 24931-24940, July 1, 2005
Raf Kinase Inhibitory Protein Regulates Raf-1 but Not B-Raf Kinase Activation*
Nicholas Trakul ¶,
Raymond E. Menard ¶,
George R. Schade ||,
Zhijian Qian||, and
Marsha Rich Rosner **
From the
Committee on Cancer Biology, the Ben May Institute for Cancer Research, and the Departments of ||Medicine and **Neurobiology, Pharmacology, and Physiology, University of Chicago, Chicago, Illinois 60637
Raf kinase inhibitory protein (RKIP; also known as phosphatidylethanolamine-binding protein or PEBP) is a modulator of the Raf/MAPK signaling cascade and a suppressor of metastatic cancer. Here, we show that RKIP inhibits MAPK by regulating Raf-1 activation; specifically, RKIP acts subsequent to Raf-1 membrane recruitment, prevents association of Raf-1 and p21-activated kinase (PAK), and blocks phosphorylation of the Raf-1 kinase domain by PAK and Src family kinases. Mutation of the PAK and Src phosphorylation sites on Raf-1 to aspartate, a phosphate mimic, prevented RKIP association with or inhibition of Raf-1 signaling. Interestingly, although RKIP can interact with B-Raf, RKIP depletion had no effect on activation of B-Raf. Because c-Raf-1 and B-Raf are both required for maximal MAPK stimulation by epidermal growth factor in neuronal and epithelial cell lines, we determined whether RKIP significantly affects MAPK signaling. In fact, RKIP depletion increased not only the amplitude but also the sensitivity of MAPK and DNA synthesis to epidermal growth factor stimulation by up to an order of magnitude. These results indicate that selective modulation of c-Raf-1 but not B-Raf activation by RKIP can limit the dynamic range of the MAPK signaling response to growth factors and may play a critical role in growth and development.
Received for publication, December 10, 2004
, and in revised form, May 5, 2005.
* This work was supported by National Institutes of Health Training Grant 5 T32 CA09594 (to N. T.) and Grant NS33858 (to M. R. R.) and by a gift from the Cornelius Crane Trust Fund for Eczema Research (to M. R. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Both authors contributed equally to this work.
 To whom correspondence should be addressed: Dept. of Neurobiology, Pharmacology, and Physiology, University of Chicago, 5841 S. Maryland Ave., MC6027, Chicago, IL 60637. Tel.: 773-702-0380; Fax: 773-702-4634; E-mail: m-rosner{at}uchicago.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Koh, K. Sachidanandam, A. N. Stratman, A. Sacharidou, A. M. Mayo, E. A. Murphy, D. A. Cheresh, and G. E. Davis
Formation of endothelial lumens requires a coordinated PKC{epsilon}-, Src-, Pak- and Raf-kinase-dependent signaling cascade downstream of Cdc42 activation
J. Cell Sci.,
June 1, 2009;
122(11):
1812 - 1822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Granovsky, M. C. Clark, D. McElheny, G. Heil, J. Hong, X. Liu, Y. Kim, G. Joachimiak, A. Joachimiak, S. Koide, et al.
Raf Kinase Inhibitory Protein Function Is Regulated via a Flexible Pocket and Novel Phosphorylation-Dependent Mechanism
Mol. Cell. Biol.,
March 1, 2009;
29(5):
1306 - 1320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Fougner, J. Bollerslev, F. Latif, J. K. Hald, T. Lund, J. Ramm-Pettersen, and J. P. Berg
Low Levels of Raf Kinase Inhibitory Protein in Growth Hormone-Secreting Pituitary Adenomas Correlate with Poor Response to Octreotide Treatment
J. Clin. Endocrinol. Metab.,
April 1, 2008;
93(4):
1211 - 1216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F Al-Mulla, S Hagan, W Al-Ali, S P Jacob, A I Behbehani, M S Bitar, A Dallol, and W Kolch
Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability
J. Clin. Pathol.,
April 1, 2008;
61(4):
524 - 529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Wang, Y. Yang, and P. A. Friedman
Na/H Exchange Regulatory Factor 1, a Novel AKT-associating Protein, Regulates Extracellular Signal-regulated Kinase Signaling through a B-Raf-Mediated Pathway
Mol. Biol. Cell,
April 1, 2008;
19(4):
1637 - 1645.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Vigneswara, J. D. Lowenson, C. D. Powell, M. Thakur, K. Bailey, S. Clarke, D. E. Ray, and W. G. Carter
Proteomic Identification of Novel Substrates of a Protein Isoaspartyl Methyltransferase Repair Enzyme
J. Biol. Chem.,
October 27, 2006;
281(43):
32619 - 32629.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|